Notably, elevated ARMC12 and MYC levels were also linked to poor outcome of adrenocortical sarcinoma, B-cell lymphoma, renal clear cell carcinoma, or breast tumor (Figure S7A-D). The gene discussed is ARMC12; the disease is breast neoplasm.